Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago

Background: Tobaceo is the fourth cause of the global burden of disease, accounting for 79.9 million loss of disability-adjusted Ufe years (DALYs) in 2001. In 2002, tobacco-attributable mortality in Chile represented 17% of total mortality. Aim: To estimate the direct cost of tobaceo in Ischemic Hea...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martínez-Gutiérrez,María Soledad, Vanegas L,Jairo, Reveco U,Sandra, Valenzuela R,Rodrigo, Arteaga H,Oscar
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2008
Materias:	Coronary disease Lung neoplasms Pulmonary disease chronic obstructive Tobaceo
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001000007
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872008001000007
record_format	dspace
spelling	oai:scielo:S0034-988720080010000072009-01-15Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de SantiagoMartínez-Gutiérrez,María SoledadVanegas L,JairoReveco U,SandraValenzuela R,RodrigoArteaga H,Oscar Coronary disease Lung neoplasms Pulmonary disease chronic obstructive Tobaceo Background: Tobaceo is the fourth cause of the global burden of disease, accounting for 79.9 million loss of disability-adjusted Ufe years (DALYs) in 2001. In 2002, tobacco-attributable mortality in Chile represented 17% of total mortality. Aim: To estimate the direct cost of tobaceo in Ischemic Heart Disease, Chronic Obstructive Pulmonary Disease and Lung Cáncer, explore patients' disposition to answer a health related expenses questionnaire, valídate the instruments used and determine an adequate sample size for an upcoming study. Material and methods: Socio-demographic and health care related variables were investigated among patients attending two publie hospitais for ischemic heart disease, chronic obstructive pulmonary disease and lung cancer, in a cross-sectional study. Costs were estimated using the national publie health insurance price list and market pnces. Tobacco-attributable fraction was then applied to calcúlate the tobacco-attributable cost ofeach disease. Results: The instruments used were validated. The group of lung cáncer patients was smaller due to increased mortality prior to interview. Lung cancer generated the largest total and attríbutable direct costs. The costs in patients with ischemic heart disease were significantly lower Conclusions: There were some difficulties in the application of the questionnaire to register medication use. The sample size needed in a larger study was calculated for each of the three diseases. We recommend that a definitive study addresses tobacco-attributable direct costs related to chronic obstructive pulmonary disease.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.10 20082008-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001000007es10.4067/S0034-98872008001000007
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Coronary disease Lung neoplasms Pulmonary disease chronic obstructive Tobaceo
spellingShingle	Coronary disease Lung neoplasms Pulmonary disease chronic obstructive Tobaceo Martínez-Gutiérrez,María Soledad Vanegas L,Jairo Reveco U,Sandra Valenzuela R,Rodrigo Arteaga H,Oscar Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
description	Background: Tobaceo is the fourth cause of the global burden of disease, accounting for 79.9 million loss of disability-adjusted Ufe years (DALYs) in 2001. In 2002, tobacco-attributable mortality in Chile represented 17% of total mortality. Aim: To estimate the direct cost of tobaceo in Ischemic Heart Disease, Chronic Obstructive Pulmonary Disease and Lung Cáncer, explore patients' disposition to answer a health related expenses questionnaire, valídate the instruments used and determine an adequate sample size for an upcoming study. Material and methods: Socio-demographic and health care related variables were investigated among patients attending two publie hospitais for ischemic heart disease, chronic obstructive pulmonary disease and lung cancer, in a cross-sectional study. Costs were estimated using the national publie health insurance price list and market pnces. Tobacco-attributable fraction was then applied to calcúlate the tobacco-attributable cost ofeach disease. Results: The instruments used were validated. The group of lung cáncer patients was smaller due to increased mortality prior to interview. Lung cancer generated the largest total and attríbutable direct costs. The costs in patients with ischemic heart disease were significantly lower Conclusions: There were some difficulties in the application of the questionnaire to register medication use. The sample size needed in a larger study was calculated for each of the three diseases. We recommend that a definitive study addresses tobacco-attributable direct costs related to chronic obstructive pulmonary disease.
author	Martínez-Gutiérrez,María Soledad Vanegas L,Jairo Reveco U,Sandra Valenzuela R,Rodrigo Arteaga H,Oscar
author_facet	Martínez-Gutiérrez,María Soledad Vanegas L,Jairo Reveco U,Sandra Valenzuela R,Rodrigo Arteaga H,Oscar
author_sort	Martínez-Gutiérrez,María Soledad
title	Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
title_short	Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
title_full	Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
title_fullStr	Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
title_full_unstemmed	Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago
title_sort	estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de santiago
publisher	Sociedad Médica de Santiago
publishDate	2008
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001000007
work_keys_str_mv	AT martinezgutierrezmariasoledad estudiopilotocostosdirectosatribuiblesaltabaquismoendoshospitalesdesantiago AT vanegasljairo estudiopilotocostosdirectosatribuiblesaltabaquismoendoshospitalesdesantiago AT revecousandra estudiopilotocostosdirectosatribuiblesaltabaquismoendoshospitalesdesantiago AT valenzuelarrodrigo estudiopilotocostosdirectosatribuiblesaltabaquismoendoshospitalesdesantiago AT arteagahoscar estudiopilotocostosdirectosatribuiblesaltabaquismoendoshospitalesdesantiago
_version_	1718436407445291008

Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago

Ejemplares similares